Thomas G. Ricks - 10 Jun 2022 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Reporting relationship: Director
Issuer ticker: SNSE
Reported as of: 10 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Jun 2022, 16:15:29 UTC
Prior SEC filing: 08 Jun 2022
Next SEC filing: 05 Jul 2022
Source filing: View source filing
Reporting owner signature: /s/ Mark Ballantyne, Attorney-in-Fact

Key filing fact

Thomas G. Ricks filed Form 4 for Sensei Biotherapeutics, Inc. (SNSE) on 14 Jun 2022.

Key facts

This page summarizes Thomas G. Ricks's Form 4 filing for Sensei Biotherapeutics, Inc. (SNSE).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Jun 2022, 16:15.

Change

Previous filing in this sequence was filed on 08 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SNSE transaction

Common Stock

Award

Transaction value: $0
Shares: +4,466
Change %
Price: $0.000000
Shares after: 4,466
Date: 10 Jun 2022
Ownership: Direct
Footnotes: F1

SNSE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 334,931
Date: 10 Jun 2022
Ownership: By Ricks Family Trust
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SNSE transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +14,550
Change %
Price: $0.000000
Shares after: 14,550
Date: 10 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,550
Exercise price: $2.05
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These shares represent restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in full on the first anniversary of the date of grant, or June 10, 2023, subject to the Reporting Person's continuous service with the Issuer through such vesting date.

Footnote F2

These shares are held by the Ricks Family Trust. Thomas Ricks is a trustee of the Ricks Family Trust and, accordingly, may be deemed to have voting and dispositive power with respect to the shares held by Ricks Family Trust.

Footnote F3

The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or June 10, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date.